| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/07/1991 | CA2024622A1 Microbiologically produced n-acyl-l-proline acylase, process of producing same and its use |
| 03/07/1991 | CA2005398A1 Alginase and a process for production thereof and bacteria used, as well as a method for decomposition of alginic acid |
| 03/06/1991 | EP0415801A1 Monoclonal antibodies against activated microglial cells |
| 03/06/1991 | EP0415565A2 Enhanced expression of heterologous proteins in recombinant hosts in a non-growth media |
| 03/06/1991 | EP0415557A2 Separation of anti-metal chelate antibodies |
| 03/06/1991 | EP0415321A1 Oligodendrocyte cytotoxic factor |
| 03/06/1991 | EP0415296A2 High alkaline proteases |
| 03/06/1991 | EP0415219A1 ANF-Antagonist |
| 03/06/1991 | EP0414870A1 Nitrate reductase as marker for filamentous fungi |
| 03/06/1991 | EP0414812A1 Extraction of human interleukin-4 from bacteria |
| 03/06/1991 | EP0414807A1 Human mammary cell growth inhibitor and methods of production and use |
| 03/06/1991 | EP0414728A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |
| 03/06/1991 | EP0162054B1 Production of cdna representing hepatitis a viral sequences |
| 03/06/1991 | EP0131623B1 Chimeric genes suitable for expression in plant cells |
| 03/05/1991 | WO1991003546A1 Arginine-rich yeast |
| 03/05/1991 | US4997915 Purification of pertussis toxins |
| 03/05/1991 | US4997767 Genetic engineering |
| 03/05/1991 | US4997760 Novel ganglioside ceramidase isolated from Nocardia and process for producing same |
| 03/05/1991 | US4997756 Process for preparing sorbic acid |
| 03/05/1991 | CA2041653A1 Yeast with high content of arginine |
| 03/05/1991 | CA2024554A1 Process for producing thiamine phosphates |
| 03/05/1991 | CA2024145A1 Expression plasmids and use thereof |
| 03/05/1991 | CA2023496A1 Process for preparing a glucane-containing product starting from candida albicans bmm-12 |
| 03/05/1991 | CA1280986C Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same |
| 03/02/1991 | CA2024053A1 Anf-antagonist |
| 03/01/1991 | WO1991003738A1 Immunochemical reagents and methods for monitoring industrial fermentation |
| 03/01/1991 | CA2039178A1 Reactives and immunochemical methods for measuring microorganisms growing and proteins quantity during industrial fermentation |
| 03/01/1991 | CA2024030A1 Oligodendrocyte cytotoxic factor |
| 03/01/1991 | CA2023320A1 Stabilization of glucose oxidase enzyme in liquid reagent |
| 03/01/1991 | CA2022762A1 Cloned dna sequences originating from soybean chlorotic mottle virus genome |
| 02/27/1991 | EP0414475A1 Methods for culturing HCV in eukaryotic cells |
| 02/27/1991 | EP0414404A2 Process for encapsulation of biologicals |
| 02/27/1991 | EP0414374A2 Novel antigens and methods for their preparation |
| 02/27/1991 | EP0414355A1 Feline interferon and process for production thereof by a silkworm virus vector |
| 02/27/1991 | EP0414297A1 Efficient production of mutant proteases |
| 02/27/1991 | EP0414282A1 Bleach compositions containing micro-organism encapsulated perfumes |
| 02/27/1991 | EP0414247A2 Cloning, expression and sequencing of an ester hydrolase genein escherichia coli |
| 02/27/1991 | EP0414178A2 Non-human primate CD4 polypeptides and human CD4 molecules capable of being glycosylated |
| 02/27/1991 | EP0414134A1 Method for producing antiviral protein utilizing E.coli transformant, and gene and E.coli vector used in the method |
| 02/27/1991 | EP0414035A2 Gibbon ape leukemia virus receptor |
| 02/27/1991 | EP0414007A2 A novel arginine deiminase, its manufacturing method and an anti-cancer agent containing this enzyme as an effective ingredient |
| 02/27/1991 | EP0413967A1 Novel antibiotic |
| 02/27/1991 | EP0413958A1 Type II restriction endonuclease DsaV |
| 02/27/1991 | EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it |
| 02/27/1991 | EP0413818A1 Process for producing a human neutrophil chemotactic factor polypeptide. |
| 02/27/1991 | EP0413794A1 Periodontal and bone regeneration factor, materials and methods |
| 02/27/1991 | EP0413777A1 TYPE II RESTRICTION ENDONUCLEASE MamI |
| 02/27/1991 | EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 02/27/1991 | EP0413738A1 Vectors encoding hcmv glycoprotein and expression products |
| 02/27/1991 | EP0413727A1 Blood platelet lysate, method of its preparation and a cell culture medium containing said blood platelet lysate. |
| 02/27/1991 | EP0413721A1 Human gm-csf variants |
| 02/27/1991 | CN1049523A Escherichia coli vaccine |
| 02/26/1991 | WO1991002820A1 Methods for culturing hcv in eukaryotic cells |
| 02/26/1991 | US4996297 contraceptives for non-rodent mammals |
| 02/26/1991 | US4996155 Insect control |
| 02/26/1991 | US4996151 Method for producing the Eag I restriction endonuclease and methylase |
| 02/26/1991 | US4996149 Microbiological hydroxylation process of quinine, quinidine and derivatives thereof |
| 02/26/1991 | US4996148 Aerobic fermentation of Kibdelosporangium |
| 02/26/1991 | US4996147 Process for producing L-threonine by fermentation |
| 02/26/1991 | CA2023969A1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
| 02/26/1991 | CA1280705C Solvents and process for extractive fermentation |
| 02/26/1991 | CA1280704C Production of beer |
| 02/26/1991 | CA1280703C Tylosin resistance-conferring gene, designated tlrb, for use in streptomyces and other organisms |
| 02/26/1991 | CA1280693C Purification of pertussis antigens |
| 02/25/1991 | CA2023892A1 Cloning, expression and sequencing of an ester hydrolase gene in escherichia coli |
| 02/25/1991 | CA2023819A1 Gibbon ape leukemia virus receptor |
| 02/24/1991 | WO1991002743A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
| 02/24/1991 | CA2065010A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
| 02/22/1991 | WO1991002744A1 Bone-specific protein |
| 02/22/1991 | CA2064878A1 Bone-specific protein |
| 02/21/1991 | WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/21/1991 | WO1991002085A1 Method of screening for protein inhibitors and activators |
| 02/21/1991 | WO1991002078A1 Tumour necrosis factor binding ligands |
| 02/21/1991 | WO1991002069A1 Plants with modified flowers |
| 02/21/1991 | WO1991002062A2 C-erbb-2 external domain: gp75 |
| 02/21/1991 | WO1991002061A1 Recombinant human thyroid peroxidase |
| 02/21/1991 | WO1991002058A1 Production of vascular endothelial cell growth factor |
| 02/21/1991 | WO1991002056A1 Cell lineages expressing a biologically active ix factor |
| 02/21/1991 | WO1991001744A2 Uses of interleukin-4 and method for purifying it |
| 02/21/1991 | WO1991001743A1 Stabilized protein or peptide conjugates |
| 02/21/1991 | WO1991001639A1 Methods and compositions for ameliorating the symptoms of sepsis |
| 02/21/1991 | WO1991000353A3 MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY |
| 02/21/1991 | CA2064753A1 Uses of interleukin-4 and method for purifying it |
| 02/21/1991 | CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/21/1991 | CA2039153A1 Cell lineage expressing a factor ix biologically active |
| 02/20/1991 | EP0413622A1 Albumin derivatives with therapeutic functions |
| 02/20/1991 | EP0413477A1 Monoclonal Antibody |
| 02/20/1991 | EP0413383A1 Mutants of human interleukin-3 |
| 02/20/1991 | EP0413378A1 Escherichia coli vaccine |
| 02/20/1991 | EP0413285A2 Fermentation process for creatinine iminohydrolase |
| 02/20/1991 | EP0413053A1 Process for producing useful substance from edible basidiomycete mycelium |
| 02/20/1991 | EP0413052A1 Process for producing Auricularia polytricha extract |
| 02/20/1991 | EP0413019A1 Synthetic plant genes and method for preparation |
| 02/20/1991 | EP0412970A1 Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
| 02/20/1991 | CN1011704B Method for production of cytidine and/or deoxycytidine |
| 02/19/1991 | WO1991002794A1 Nucleic acid fragments and diagnostic reagents derived from the hhv6/sie genome and procedures for diagnosing hhv6 infections |
| 02/19/1991 | WO1991002755A1 Fibulin |
| 02/19/1991 | WO1991002546A1 A reagent for the detection of fibrinolytic activity |
| 02/19/1991 | US4994582 Novel antibiotic NK130119 |
| 02/19/1991 | US4994565 Nucleotide sequence of gene specifically expressed by insulinoma |